|
|
Blood, 15 January 2005, Vol. 105, No. 2, pp. 830-837.
Prepublished online as a Blood First Edition Paper on September 9, 2004; DOI 10.1182/blood-2004-02-0564.
 Previous Article | Table of Contents | Next Article 
PHAGOCYTES
Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases
Patrizia Scapini,
Antonio Carletto,
Bernardetta Nardelli,
Federica Calzetti,
Viktor Roschke,
Flavia Merigo,
Nicola Tamassia,
Sara Pieropan,
Domenico Biasi,
Andrea Sbarbati,
Silvano Sozzani,
Lisa Bambara, and
Marco A. Cassatella
From the Department of Pathology, Division of General Pathology, the Department of Clinical and Experimental Medicine, Division of Rheumatology, and the Department of Morphological and Biomedical Sciences, Division of Anatomy and Histology, University of Verona; the Department of Biotechnology, Division of General Pathology and Immunology, University of Brescia; IRF "Mario Negri," Milan, Italy; and Human Genome Sciences, Rockville, MD.
We have recently shown that granulocyte–colony-stimulating factor (G-CSF)– and interferon- (IFN-)–activated human neutrophils accumulate and release remarkable amounts of soluble B-lymphocyte stimulator (BLyS) in vitro. In this study, we provide evidence that neutrophils migrating into skin window exudates (SWEs) developed in healthy volunteers and in patients with rheumatoid arthritis (RA), synthesized, and released BLyS in response to locally produced G-CSF. Accordingly, the concentrations of soluble BLyS in SWEs were significantly more elevated than in serum. Because the levels of SWE BLyS, but not SWE G-CSF, were higher in patients with RA than in healthy subjects, we examined the effect of CXCL8/IL-8, C5a, and other proinflammatory mediators that dramatically accumulate in RA SWEs and in inflamed synovial fluids. We show that CXCL1/GRO , CXCL8/IL-8, C5a, immune complexes, tumor necrosis factor- (TNF-), leukotriene B4, N-formyl-methionyl-leucyl-phenylalanine (fMLP), and lipopolysaccharide (LPS), which by themselves do not induce BLyS de novo synthesis, act as potent secretagogues for BLyS, which is mainly stored in Golgi-related compartments within G-CSF–treated neutrophils, as determined by immunogold electron microscopy. This action is pivotal in greatly amplifying neutrophil-dependent BLyS release in SWEs of patients with RA compared with healthy subjects. Collectively, our data uncover a novel mechanism that might dramatically exacerbate the release of BLyS by neutrophils during pathologic inflammatory responses.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D T La, C E Collins, H-T Yang, T-S Migone, and W Stohl
B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor {alpha} antagonists: differential effects between good and poor clinical responders
Ann Rheum Dis,
August 1, 2008;
67(8):
1132 - 1138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Krumbholz, H. Faber, F. Steinmeyer, L.-A. Hoffmann, T. Kumpfel, H. Pellkofer, T. Derfuss, C. Ionescu, M. Starck, C. Hafner, et al.
Interferon-{beta} increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
Brain,
June 1, 2008;
131(6):
1455 - 1463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Bossen, T. G. Cachero, A. Tardivel, K. Ingold, L. Willen, M. Dobles, M. L. Scott, A. Maquelin, E. Belnoue, C.-A. Siegrist, et al.
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Blood,
February 1, 2008;
111(3):
1004 - 1012.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yoshimoto, Y. Takahashi, M. Ogasawara, Y. Setoyama, K. Suzuki, K. Tsuzaka, T. Abe, and T. Takeuchi
Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy
Int. Immunol.,
July 1, 2006;
18(7):
1189 - 1196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Cassatella, V. Huber, F. Calzetti, D. Margotto, N. Tamassia, G. Peri, A. Mantovani, L. Rivoltini, and C. Tecchio
Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators
J. Leukoc. Biol.,
January 1, 2006;
79(1):
123 - 132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Nieminen, C. St-Pierre, and S. Sato
Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses
J. Leukoc. Biol.,
November 1, 2005;
78(5):
1127 - 1135.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
